TY  - JOUR
AU  - Mora Raimundo, P.
AU  - Manzano García, Miguel
AU  - Vallet Regí, María Dulce Nombre
PY  - 2017
DO  - 10.3934/bioeng.2017.2.259
SN  - 2375-1495
UR  - https://hdl.handle.net/20.500.14352/18490
T2  - AIMS Bioengineering
AB  - Osteoporosis is by far the most frequent metabolic disease affecting bone. Current clinical therapeutic treatments are not able to offer long-term solutions. Most of the clinically used antiosteoporotic drugs are administered systemically, which might...
LA  - eng
M2  - 259
PB  - AIMS Press
KW  - Nanoparticles
KW  - Osteoporosis
KW  - Drug delivery system
KW  - Anti-osteoporotic drugs
KW  - Osteoclast
KW  - Osteoblast
KW  - Bone-targeting
TI  - Nanoparticles for the tratment of osteoporosis
TY  - journal article
VL  - 4
ER  -